Chemomab Therapeutics (NASDAQ:CMMB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Chemomab Therapeutics (CMMB) operate in?

Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Chemomab Therapeutics Stock (NASDAQ: CMMB) stock price, news, charts, stock research, profile.

Open	$0.94
Close	$0.97
Volume / Avg.	15.45K / 97.50K
Day Range	0.91 - 0.97
52 Wk Range	0.42 - 1.50
Market Cap	$13.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	0.71%
Days to Cover	1

Recent News

What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?

Chemomab Therapeutics' CM-101 granted new patents in Brazil and Israel, currently in Phase 2 SPRING trial for primary sclerosing cholangitis. Topline data readout expected by mid-2024.

Vandana Singh

Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Shares of M.D.C. Holdings, Inc. (NYSE: MDC) rose sharply in today’s pre-market trading. Sekisui House, Ltd. and M.D.C. Holdings announced an agreement pursuant to which a wholly-owned subsidiary of Sekisui House will acquire MDC in an all-cash deal with an equity value of $4.9 billion.

Avi Kapoor

Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Chemomab Therapeutics Ltd

Sector

Health Care

Industry

Biotechnology

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and develop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Chemomab Therapeutics (CMMB) stock?

You can purchase shares of Chemomab Therapeutics (NASDAQ:CMMB) through any online brokerage.

View our list of the best stock brokerages

Who are Chemomab Therapeutics (CMMB) competitors?

Other companies in Chemomab Therapeutics’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Lumos Pharma (NASDAQ:LUMO).

What is the target price for Chemomab Therapeutics (CMMB) stock?

There is no analysis for Chemomab Therapeutics.

What is the forecast for Chemomab Therapeutics (CMMB) stock?

Chemomab Therapeutics has a consensus price target of $11.75.

Current stock price for Chemomab Therapeutics (CMMB)?

The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $0.9693 last updated July 2, 2024 at 7:29 PM EDT.

Does Chemomab Therapeutics (CMMB) pay a dividend?

There are no upcoming dividends for Chemomab Therapeutics.

When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?

Chemomab Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is Chemomab Therapeutics (CMMB) going to split?

There is no upcoming split for Chemomab Therapeutics.

What sector and industry does Chemomab Therapeutics (CMMB) operate in?

Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Chemomab Therapeutics

Chemomab Therapeutics (CMMB) Forecast